# FDA Warning Letter: North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
> 2023-01-24 · Division of Pharmaceutical Quality Operations II · `76baf8ecd5146361`
## Letter
- **Company:** North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
- **Posted Date:** 2023-01-24
- **Letter Issue Date:** 2022-11-18
- **Issuing Office:** Division of Pharmaceutical Quality Operations II
## Subject
Compounding Pharmacy/Adulterated Drug Products
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*